GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.7743 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8835 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, FABP3, FABP4, FUT7, HMGCR, HSD17B1, HSD17B2, KIT, MET, PPARA |
10.298 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GLO1, HMGCR, PDE5A, PIM1, PPARA, TYR, XDH |
10.2803 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, KIT, MAOB, MMP9, SRC, TERT |
10.2802 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD2, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
10.052 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.6032 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD2, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP2, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
9.29033 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, F10, FLT3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PDE5A, SRC, TERT, TNKS, TNKS2, XDH |
8.31759 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, F10, FLT3, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PDE5A, SRC, TERT, TNKS, TNKS2, XDH |
8.29929 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD2, FABP3, HMGCR, HSD17B2, IGF1R, MAOB, MMP2, MMP9, PPARA, SRC, TYR |
7.33227 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD2, F10, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, KDR, KIT, MAOB, MET, PPARA, SRC, TERT, TNKS, TNKS2, XDH |
7.32935 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, KIT, MAOB, MMP2, PPARA, SRC, TYR |
7.28783 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD2, FABP3, FABP4, FLT3, HMGCR, HSD17B2, IGF1R, KDR, KIT, MAOB, MMP2, MMP9, PPARA, SRC, TERT, TYR |
7.28783 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, ALPI, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, FABP3, FABP4, FUT7, HMGCR, KIT, MET, PPARA |
7.10526 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
6.75837 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.20576 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, DNMT1, DRD2, FABP3, FLT3, HMGCR, HTR1A, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PDE5A, PIM1, SRC, TERT, XDH |
6.20576 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD2, DYRK1A, F10, FABP3, FLT3, HCAR2, HMGCR, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
6.20576 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HMGCR, HSD17B1, HSD17B2 |
6.11209 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F10, FLT3, HMGCR, KDR, KIT, MET, MMP12, MMP9, PDE5A, SRC, TERT, TNKS, TNKS2, XDH |
6.11199 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MAOB, MMP9, TERT |
6.08892 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DYRK1A, F10, FLT3, HCAR2, HMGCR, HTR1A, IGF1R, KDR, KIT, MET, MMP12, MMP9, PDE5A, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
6.04687 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, HSD17B2, MAOB, TYR, XDH |
6.01659 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.94133 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DYRK1A, F10, FLT3, HCAR2, HMGCR, HTR1A, IGF1R, KDR, KIT, MET, MMP12, MMP9, PDE5A, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
5.94133 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, HMGCR, HTR1A, MAOB, TYR |
5.91575 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.72941 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD2, DYRK1A, F10, FABP3, FABP4, FLT3, HCAR2, HMGCR, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.68604 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SRC, TERT, TOP2A, XDH |
5.56092 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, PPARA |
5.50067 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, F10, HCAR2, HMGCR, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, PPARA, SRC, TERT |
5.50007 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, FABP3, FLT3, IGF1R, KIT, MAOB, MMP2, PPARA, SRC |
5.48513 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DYRK1A, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B2, KDR, KIT, MAOB, MET, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS2, TOP2A, TYR |
5.47417 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
5.47387 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.36395 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.36395 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD2, HMGCR, KDR, MAOB, SRC |
5.1487 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.00073 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, PPARA, SRC, TERT |
4.94325 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.91409 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPI, ALPL, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PDE5A, PIM1, PTPRS, SRC, TNKS, XDH |
4.91409 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FLT3, MAOB, SRC, TYR |
4.91409 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, F10, FLT3, HMGCR, KDR, KIT, MET, PDE5A, SRC, XDH |
4.81045 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, F10, FABP4, HMGCR, HSD17B2, HTR1A, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, SRC, TNKS2, TYR |
4.74278 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F10, FABP4, FLT3, HMGCR, KDR, KIT, MET, MMP12, MMP2, MMP9, PDE5A, SRC, TERT, TNKS, TNKS2, XDH |
4.74185 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PIM1, SRC, TERT |
4.74185 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.63623 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, KIT, MAOB, PPARA, SRC |
4.62231 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.61312 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, DRD2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.60295 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPI, ALPL, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, PDE5A, PIM1, PTPRS, SRC, TNKS, XDH |
4.60295 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.59575 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD2, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
4.58561 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
4.54047 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, DRD2, HCAR2, HMGCR, KDR, SRC, TNKS, TNKS2 |
4.49692 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT |
4.36989 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.29058 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC, TERT, TOP2A, XDH |
4.28744 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, F10, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP9, PDE5A, SRC, XDH |
4.28175 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD2, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, KIT, MAOB, MMP12, MMP2, MMP9, PPARA, SRC, TERT, TOP2A, TYR |
4.26292 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, SRC, XDH |
4.23608 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, HSD17B2, MAOB, SRC, TYR |
4.23608 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A |
4.21918 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD2, FABP3, HMGCR, KDR, MAOB, SRC |
4.1439 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD2, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
4.10876 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.07851 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD2, DYRK1A, FABP3, FABP4, GLO1, HCAR2, HMGCR, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
4.0672 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, HTR1A, MAOB, TYR |
4.0585 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.04927 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPI, ALPL, APP, AURKB, AXL, BACE1, BCL2, CSNK2A1, CYP1A1, CYP1A2, DRD2, DYRK1A, F10, FLT3, FUT7, GLO1, HMGCR, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.04493 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, FLT3, HMGCR, HTR1A, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, TERT |
4.00267 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD2, DYRK1A, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.97645 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.8201 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD2, DYRK1A, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HCAR2, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
3.78983 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DYRK1A, KIT, PPARA, SRC, TOP2A |
3.7878 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HMGCR, SRC, TNKS, TNKS2 |
3.75318 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, SRC |
3.69308 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PPARA |
3.68415 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.51611 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.51611 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.51611 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.51611 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, SRC, TERT |
3.48538 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, HMGCR, KDR, KIT, PDE5A, SRC, XDH |
3.44365 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, HMGCR, KIT, MMP2, PPARA, SRC, TERT, TYR |
3.39844 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DYRK1A, F10, FLT3, IGF1R, KDR, KIT, MET, SRC, TNKS, TOP2A |
3.36233 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.34413 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.34413 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
3.34413 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.34413 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DNMT1, DRD2, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.27696 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
3.27518 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CYP1A1, FLT3, HTR1A, KIT, MET, PIM1, SRC, TYR |
3.24145 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, F10, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PDE5A, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.24145 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD17B2, KDR, KIT, PPARA, PTPRS, SRC, TYR |
3.22049 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
3.20814 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
3.20676 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.19692 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD2, DYRK1A, F10, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PDE5A, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, XDH |
3.18126 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
3.18126 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD2, HTR1A, MAOB |
3.18126 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
3.15537 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.14445 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR |
3.10994 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
3.10994 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD2, HCAR2, HMGCR, HTR1A, MAOB, MMP12, MMP9, PPARA, SRC, TERT |
3.1074 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
3.1074 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.10226 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.10226 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.09393 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.09393 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HCAR2, HMGCR, KIT, PPARA, SRC |
3.06338 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
3.00969 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
2.97208 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DNMT1, FABP4, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, SRC, TERT, TOP2A |
2.96546 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, TERT |
2.94446 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, HMGCR, IGF1R, KDR, KIT, PDE5A, SRC, XDH |
2.92001 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, DNMT1, DRD2, DYRK1A, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.91137 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F10, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
2.89861 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC, TERT |
2.87966 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD2, KDR, SRC |
2.87244 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, TYR |
2.86384 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F10, KIT, MET, SRC, XDH |
2.83765 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DYRK1A, FLT3, HSD17B2, KDR, KIT, MAOB, MMP9, PIM1, PPARA, PTPRS, SRC, TYR |
2.83384 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DRD2, DYRK1A, FABP4, HMGCR, IGF1R, MET, MMP12, MMP2, PPARA, PTPRS, SRC, TERT, XDH |
2.80459 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD2, KIT |
2.79841 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD2, KIT |
2.79841 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.78119 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, SRC, TNKS |
2.76697 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, ALPI, CSNK2A1, DRD2, FABP3, FABP4, KIT, MET |
2.7569 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, FABP3, FLT3, HMGCR, IGF1R, KDR, KIT, MAOB, MET, MMP12, MMP9, PDE5A, PPARA, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.75422 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DNMT1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.71726 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, HCAR2, TNKS, TNKS2 |
2.67968 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.66557 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, DRD2, MAOB |
2.65436 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, FABP3, FABP4, FLT3, MET, SRC, TERT |
2.61745 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.61187 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, DNMT1, DRD2, DYRK1A, FLT3, HMGCR, KDR, KIT, MMP9, PDE5A, SRC, XDH |
2.61187 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CYP1B1, DRD2, HCAR2, HMGCR, KDR, KIT, MET, MMP12, MMP9, PDE5A, PIM1, SRC, TERT |
2.57816 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, ALPI, CSNK2A1, CYP19A1, CYP1A1, HMGCR, HSD17B1, HSD17B2 |
2.49754 |
[BP] GO:0008542 |
None
|
APP, DRD2, HMGCR, KIT |
2.49398 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD2, FLT3, HMGCR, KDR, KIT, MMP9, PDE5A, SRC, XDH |
2.48048 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, TYR |
2.47339 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.45579 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.45117 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, BCL2, DRD2, FABP3, FLT3, HMGCR, KDR, KIT, MMP9, PDE5A, SRC, XDH |
2.45117 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, DRD2, FABP3, FLT3, HMGCR, KDR, KIT, MMP9, PDE5A, SRC, XDH |
2.45117 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DNMT1, DRD2, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
2.43439 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MAOB |
2.42438 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD2, HCAR2, MMP12, SRC, TERT |
2.42412 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, TYR |
2.41712 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MET, MMP12, MMP9, PDE5A, PPARA, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.37744 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.36284 |
[BP] GO:0007632 |
None
|
APP, DRD2, HMGCR, KIT |
2.3603 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.3603 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, KIT, MMP9 |
2.34238 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.33934 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD2, FLT3, HMGCR, KDR, KIT, MMP9, PDE5A, SRC, XDH |
2.32517 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.30944 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, KIT, MMP9, TERT |
2.27884 |
[BP] GO:2001251 |
None
|
DNMT1, SRC, TNKS, TNKS2, TOP2A |
2.27748 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
2.27291 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.26685 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.22863 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CYP19A1, DRD2, DYRK1A, HMGCR, IGF1R, MET, MMP12, MMP9, PPARA, PTPRS, SRC, TERT, XDH |
2.22661 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, DRD2, HTR1A, MAOB, MMP9 |
2.21074 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, TERT, TNKS, TNKS2 |
2.20438 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.17982 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.17982 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
2.17777 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PDE5A, PPARA, SRC, XDH |
2.17686 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.17607 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.164 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.164 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, SRC |
2.16225 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, SRC |
2.15852 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.15241 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, HMGCR, KIT, TYR |
2.15241 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD2 |
2.1386 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HMGCR, KDR, SRC |
2.13678 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.13678 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.13075 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.13075 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC |
2.11469 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.10398 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, HMGCR |
2.08537 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.08144 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HMGCR, HSD17B1, HSD17B2 |
2.07489 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DRD2, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PDE5A, SRC, XDH |
2.07489 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.07489 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DYRK1A, HMGCR, IGF1R, MET, MMP9, SRC, XDH |
2.07227 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AURKB, BACE1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, MAOB, PDE5A, XDH |
2.05415 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, HMGCR, MMP2, MMP9, TERT |
2.05241 |
[BP] GO:0048169 |
None
|
APP, DRD2, KIT |
2.05241 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, SRC, TERT |
2.04877 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, TNKS2 |
2.04877 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CYP19A1, DRD2, MMP12, PDE5A, PTPRS |
2.04822 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, DRD2, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, KIT, MMP9, PDE5A, PPARA, SRC, XDH |
2.03639 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.01132 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALOX5, ALPI, ALPL, APP, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, F10, FLT3, FUT7, GLO1, HCAR2, HMGCR, HSD17B2, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP2, PIM1, PTPRS, SRC, TERT, TNKS, TNKS2, TYR |
2.80459 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, ALPI, ALPL, APP, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD2, F10, FLT3, GLO1, HCAR2, HTR1A, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPRS, SRC, TERT |
2.16477 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DRD2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, KDR, KIT, MAOB, MMP2, MMP9, PDE5A, PIM1, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
2.07682 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APEX1, APP, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD2, DYRK1A, FABP3, FABP4, FLT3, FUT7, GLO1, HMGCR, IGF1R, KDR, KIT, MAOB, MMP12, MMP2, MMP9, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
1.90387 |
[CC] GO:0030424 |
None
|
APP, BACE1, CA2, DRD2, PTPRS, TUBB3 |
1.67418 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPI, ALPL, APEX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DYRK1A, F10, FLT3, FUT7, GLO1, HMGCR, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
17.2584 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
17.2584 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD2, DYRK1A, F10, FABP3, FABP4, FLT3, GLO1, HMGCR, HSD17B1, HTR1A, IGF1R, KDR, KIT, MAOB, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPRS, SRC, TERT, TNKS, TNKS2, TOP2A, TUBB3, TYR, XDH |
15.6718 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, ALPI, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, TNKS, TYR, XDH |
15.5246 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.1086 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8835 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, DRD2, F10, GLO1, HTR1A, KIT, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
9.17648 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
8.5362 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPI, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DNMT1, F10, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, PDE5A, PIM1, PPARA, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
7.37544 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, HSD17B2, MAOB, TYR, XDH |
7.28783 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, TNKS |
6.58099 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.55045 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
5.56092 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.16372 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.7626 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.56562 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
4.15313 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC, TOP2A |
4.0585 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.04927 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.04493 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.89874 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2, XDH |
3.89874 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
3.86035 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, MAOB, SRC, XDH |
3.65309 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
3.55524 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, DYRK1A, F10, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MAOB, MET, PDE5A, PIM1, PTPRS, SRC, TOP2A, TUBB3, XDH |
3.18784 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD17B1, HSD17B2 |
3.15206 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.00969 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MAOB, MET, PDE5A, PIM1, SRC, TOP2A, TUBB3, XDH |
2.99581 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, DRD2, DYRK1A, FLT3, HMGCR, IGF1R, KDR, KIT, MAOB, MET, MMP9, TERT, TOP2A, TYR, XDH |
2.80153 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.76932 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.61745 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MAOB, MET, PDE5A, PIM1, SRC, TOP2A, TUBB3, XDH |
2.45117 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, AURKB, AXL, CSNK2A1, DNMT1, DYRK1A, FLT3, HMGCR, HSD17B1, IGF1R, KDR, KIT, MAOB, MET, PDE5A, PIM1, SRC, TOP2A, TUBB3, XDH |
2.45117 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, MAOB, XDH |
2.32564 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.03818 |